Skip to content

Turning the tide of antimicrobial resistance in intensive care units in Indonesia

Turning the tide of antimicrobial resistance in intensive care units in Indonesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26918
Enrollment
550
Registered
2015-12-22
Start date
2013-04-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antimicrobial resistance, Intensive care

Interventions

1.Contact Isolation Precautions for patients colonized or infected with a carbapenem non-susceptible Gram-negative bacterium (Pseudomonas aeruginosa, Klebsiella pneumoniae, or Acinetobacter baumannii)
4 times daily --> 2% solutions of chlorhexidine 4. Environmental cleaning 5. Antibiotic Stewardship 6. Multifaceted program to improve hand hygiene compliance (including education, feedba

Sponsors

1.Faculty of Medicine Universitas Indonesia / Dr Cipto Mangunkusumo Hospital Jakarta, Indonesia 2. Erasmus MC Rotterdam, The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients (age ≥18 years old) admitted to the intensive care unit of Dr Cipto Mangunkusumo Hospital in Jakarta, Indonesia.

Exclusion criteria

Exclusion criteria: Patients who are discharged within 48 hours from the intensive care unit.

Design outcomes

Primary

MeasureTime frame
The number of patients who acquire carriage or infection with A. baumannii with reduced susceptibility to carbapenems, P. aeruginosa with reduced susceptibility to carbapenems, or K. pneumoniae with reduced susceptibility to carbapenems per 100 patient-days at risk in the ICU. An acquisition is defined as a screening culture (throat or rectum) or clinical culture with a first detection of either A. baumannii, P. aeruginosa, or K. pneumoniae, all with reduced susceptibility to a carbapenem, that was not yet present on admission or in the first 48 hours of admission. Thus, for each patient, a maximum of three new acquisition events may occur.

Secondary

MeasureTime frame
Measures include quantity and quality of antibiotic usage, the in-ICU crude mortality rate, the hand hygiene compliance of health care workers, and environmental contamination of the above mentioned Gram-negative bacteria with reduced susceptibility to carbapanems.

Contacts

Public ContactJuliette Severin

Erasmus MC

j.severin@erasmusmc.nl010-7033510

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)